BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-422@pharmaconomics
DTSTAMP:20260707T041631Z
DTSTART;VALUE=DATE:20260501
DTEND;VALUE=DATE:20260502
SUMMARY:AQST Catalyst — Anaphylm
DESCRIPTION:A key catalyst for Anaphylm (treatment of Type I allergic reactions\, including anaphylaxis) is expected May 1\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000029/earningsreleasesupplemen.htm\n\nTrack it: https://pharmaconomics.com/e/422
URL:https://pharmaconomics.com/e/422
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AQST catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR